NCT03997383
APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)
ALNY — ALNYLAM PHARMACEUTICALS, INC.
Phase 3
• Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
TL;DR
Locations updated — PHASE3
What changed
Recent events (last 90 days)
What to check next
- Review CT.gov update history and company disclosures for context.
- Verify whether registry updates lag press releases.